{"url": "https://www.statnews.com/2018/01/12/inherited-breast-cancer-drug-fda/", "text": "FDA approves first drug aimed at women with inherited breast cancer\n\nU.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene.\n\nThe Food and Drug Administration on Friday approved AstraZeneca (AZN) PLC\u2019s Lynparza for patients with inherited BRCA gene mutations who have undergone chemotherapy.", "images": ["https://www.statnews.com/wp-content/uploads/2016/03/AmarinFDA-645x645.jpg", "https://www.statnews.com/wp-content/uploads/2016/03/AmarinFDA-1024x576.jpg", "https://www.statnews.com/wp-content/uploads/2019/08/Newsletter-Logo-Images-DR.png", "https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg", "https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/330x400-00000000.png", "https://dc.ads.linkedin.com/collect/?pid=46858&fmt=gif", "https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg", "https://www.facebook.com/tr?id=436331036555416&ev=PageView&noscript=1"], "top_img": "https://www.statnews.com/wp-content/uploads/2016/03/AmarinFDA-1024x576.jpg", "keywords": [], "authors": ["Associated Press", "Shraddha Chakradhar", "Sharon Begley", "Megan Thielking", "Elizabeth Preston"], "canonical_link": "https://www.statnews.com/2018/01/12/inherited-breast-cancer-drug-fda/", "title": "FDA approves first drug aimed at women with inherited breast cancer", "meta_data": {"viewport": "width=device-width, initial-scale=1", "referrer": "origin", "description": "It's the first in a fairly new class of medicines for ovarian cancer called PARP inhibitors to also win approval for treating breast cancer.", "og": {"locale": "en_US", "type": "article", "title": "FDA approves first drug aimed at women with inherited breast cancer", "description": "It's the first in a fairly new class of medicines for ovarian cancer called PARP inhibitors to also win approval for treating breast cancer.", "url": "https://www.statnews.com/2018/01/12/inherited-breast-cancer-drug-fda/", "site_name": "STAT", "updated_time": "2018-01-12T19:54:00+00:00", "image": {"identifier": "https://www.statnews.com/wp-content/uploads/2016/03/AmarinFDA-1024x576.jpg", "secure_url": "https://www.statnews.com/wp-content/uploads/2016/03/AmarinFDA-1024x576.jpg", "width": 1024, "height": 576}}, "article": {"publisher": "http://facebook.com/statnews/", "tag": "pharmaceuticals", "section": "Health", "published_time": "2018-01-12T19:26:07+00:00", "modified_time": "2018-01-12T19:54:00+00:00"}, "fb": {"app_id": 933808010032702, "pages": 1456948254627841}, "twitter": {"card": "summary_large_image", "description": "It's the first in a fairly new class of medicines for ovarian cancer called PARP inhibitors to also win approval for treating breast cancer.", "title": "FDA approves first drug aimed at women with inherited breast cancer", "site": "@statnews", "image": "https://www.statnews.com/wp-content/uploads/2016/03/AmarinFDA-1024x576.jpg", "creator": "@statnews"}, "generator": "WordPress 5.2.4", "apple-itunes-app": "app-id=1324796990", "msapplication-TileImage": "https://www.statnews.com/wp-content/uploads/2015/10/cropped-stat-logo-teal-328x328.png"}, "movies": [], "publish_date": 1515733200.0, "source": "https://www.statnews.com", "summary": ""}